Fang et al. showed that soluble epoxide hydrolase inhibition protected against diabetic cardiomyopathy by inducing autophagy and reducing apoptosis through Nrf2 upregulation and transcriptional activation (Fang et al., 2022). The gene discussed is NFE2L2; the disease is diabetic cardiomyopathy.